Frank C. Cackowski

1.7k total citations
41 papers, 1.2k citations indexed

About

Frank C. Cackowski is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Frank C. Cackowski has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Frank C. Cackowski's work include Prostate Cancer Treatment and Research (22 papers), Cancer Cells and Metastasis (6 papers) and Immunotherapy and Immune Responses (6 papers). Frank C. Cackowski is often cited by papers focused on Prostate Cancer Treatment and Research (22 papers), Cancer Cells and Metastasis (6 papers) and Immunotherapy and Immune Responses (6 papers). Frank C. Cackowski collaborates with scholars based in United States, South Korea and Singapore. Frank C. Cackowski's co-authors include Russell S. Taichman, Ann M. Decker, Kenji Yumoto, Younghun Jung, Eunsohl Lee, Jingcheng Wang, Elisabeth I. Heath, Bo Hu, Shi‐Yuan Cheng and Matthew R. Eber and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Frank C. Cackowski

39 papers receiving 1.2k citations

Peers

Frank C. Cackowski

ONCOL

PRM

IMMUN

Justin Bottsford-Miller United States

Chien-Jui Cheng Taiwan

Ruoqian Shen United States

Yuan Zhu Germany

Song-Chang Lin United States

Dena Almeida United States

Angela Celetti Italy

Yasuhiro Yoshimatsu Japan

Shannon Matheny United States

Richard Bachelier France

Justin Bottsford-Miller United States

Frank C. Cackowski

591 ×1.0

ONCOL

559 ×1.0

163 ×0.5

PRM

324 ×1.1

258 ×2.0

IMMUN

Citations per year, relative to Frank C. Cackowski Frank C. Cackowski (= 1×) peers Justin Bottsford-Miller

Countries citing papers authored by Frank C. Cackowski

Since Specialization

Citations

This map shows the geographic impact of Frank C. Cackowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank C. Cackowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank C. Cackowski more than expected).

Fields of papers citing papers by Frank C. Cackowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank C. Cackowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank C. Cackowski. The network helps show where Frank C. Cackowski may publish in the future.

Co-authorship network of co-authors of Frank C. Cackowski

This figure shows the co-authorship network connecting the top 25 collaborators of Frank C. Cackowski. A scholar is included among the top collaborators of Frank C. Cackowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank C. Cackowski. Frank C. Cackowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pulianmackal, Ajai J., Luke V. Loftus, Sarah R. Amend, et al.. (2025). Oncogenic signaling in the Drosophila prostate-like accessory gland activates a pro-tumorigenic program in the absence of proliferation. Disease Models & Mechanisms. 18(4).

Smith, David C., Elisabeth I. Heath, Frank C. Cackowski, et al.. (2025). Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP). JCO Precision Oncology. 9(9). e2500457–e2500457.

Brown, Michael C., David Boczkowski, Nadeem A. Sheikh, et al.. (2024). Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T. Cancer Research Communications. 4(10). 2724–2733. 3 indexed citations

Heath, Elisabeth I., Archana Thakur, Wei Chen, et al.. (2024). Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate–Resistant Prostate Cancer. Cancer Research Communications. 4(7). 1715–1725. 3 indexed citations

Lee, Jessica, Lincoln W. Pasquina, Jennie L. Lovett, et al.. (2024). Prognostic value of baseline circulating tumor DNA (ctDNA) tumor fraction (TF) in metastatic hormone-sensitive prostate cancer (mHSPC).. Journal of Clinical Oncology. 42(16_suppl). 5085–5085. 1 indexed citations

Yumoto, Kenji, Steven P. Zielske, Yu Wang, et al.. (2023). HER2 as a potential therapeutic target on quiescent prostate cancer cells. Translational Oncology. 31. 101642–101642. 7 indexed citations

Zielske, Steven P., et al.. (2023). SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer. BMC Cancer. 23(1). 672–672. 3 indexed citations

Wang, Yu, Mackenzie K. Herroon, Steven P. Zielske, et al.. (2021). Use of FVB Myc-CaP cells as an immune competent, androgen receptor positive, mouse model of prostate cancer bone metastasis. Journal of bone oncology. 30. 100386–100386. 1 indexed citations

Decker, Ann M., Joseph T. Decker, Younghun Jung, et al.. (2020). Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6. Translational Oncology. 13(7). 100781–100781. 17 indexed citations

10.

Jung, Younghun, Frank C. Cackowski, Kenji Yumoto, et al.. (2020). Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow. Neoplasia. 23(1). 102–111. 21 indexed citations

11.

Wang, Yugang, Udit Singhal, Yuanyuan Qiao, et al.. (2020). Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion. Translational Oncology. 13(4). 100747–100747. 37 indexed citations

12.

Jung, Younghun, Frank C. Cackowski, Kenji Yumoto, et al.. (2018). CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes. Cancer Research. 78(8). 2026–2039. 42 indexed citations

13.

Cackowski, Frank C. & Russell S. Taichman. (2018). Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation. Bone. 119. 82–86. 16 indexed citations

14.

Decker, Ann M., et al.. (2017). Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow. Molecular Cancer Research. 15(12). 1644–1655. 58 indexed citations

15.

Cackowski, Frank C., Matthew R. Eber, James A. Van Rhee, et al.. (2016). Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy. Journal of Cellular Biochemistry. 118(4). 891–902. 66 indexed citations

16.

Decker, Ann M., Younghun Jung, Frank C. Cackowski, & Russell S. Taichman. (2016). The role of hematopoietic stem cell niche in prostate cancer bone metastasis. Journal of bone oncology. 5(3). 117–120. 21 indexed citations

17.

Yumoto, Kenji, Matthew R. Eber, Jingcheng Wang, et al.. (2016). Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow. Scientific Reports. 6(1). 36520–36520. 127 indexed citations

18.

Lee, Eunsohl, Ann M. Decker, Frank C. Cackowski, et al.. (2016). Growth Arrest‐Specific 6 (GAS6) Promotes Prostate Cancer Survival by G₁ Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow. Journal of Cellular Biochemistry. 117(12). 2815–2824. 22 indexed citations

19.

Cackowski, Frank C., Judith L. Anderson, Kenneth D. Patrene, et al.. (2009). Osteoclasts are important for bone angiogenesis. Blood. 115(1). 140–149. 143 indexed citations

20.

Cackowski, Frank C. & G. David Roodman. (2007). Perspective on the Osteoclast. Annals of the New York Academy of Sciences. 1117(1). 12–25. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact